A sensitive high-throughput HPLC assay for simultaneous determination of everolimus and clobetasol propionate

Journal of Chromatographic Science

Volumn 46, Issue 1, 2008, Pages 23-29

  Marika, Kamberi ^a   Katherine, Fu ^a   Jianmin, Lu ^a   Mike, Chemaly G ^a   Debra, Feder ^a  

^a ABBOTT VASCULAR   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 38149140177     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/46.1.23     Document Type: Article

References (32)

1. B. Nashan. Review of the proliferation inhibitor everolimus. Expert Opin. Investig. Drugs 11: 1845-57 (2002).
2. T.M. Chapman, M.P. Caroline and C.M. Perry. Everolimus. Drugs 64: 861 (2004).
3. J. Pascual. Everolimus in clinical practice-renal transplantation. Nephrol. Dial. Transplant. 21(Suppl 3:iii): 18-23 (2006).
4. M.A. Gonazales-Moles, P. Morales-Garcia, A. Rodriguez-Archilla, I. Ruiz-Ávila and S. González-Moles. Treatment of severe chronic oral erosive lesions with clobetasol propionate in aqueous solution. Oral Med. Oral Pathol. Oral Radiol. Endod. 93: 264-70 (2002).
5. G. Campisi, G. Giandalia, V. De Caro, C. Di Liberto and P. Aricò. A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus. A Phase IV, randomized, observer-blinded, parallel group clinical trial. Brit. J. Dermatol. 150: 984-90 (2004).
6. J. Del Rosso and S.F. Friedlander. Corticosteroids: options in the era of steroid-sparing therapy. J. Am. Acad. Dermatol. 53: S50-58 (2005).
7. M.A. Matthay. Severe sepsis-A new treatment with both anticoagulant and antiinflamatory properties. N. Engl. J. Med. 344: 759-62 (2001).
8. J.K. Patel and J.A. Kobashigawa. Everolimus: an immunosuppressive agent in transplantation. Expert. Opin. Pharmacother. 7: 1347-55 (2006).
9. R.N. Formica, K.M. Lorber, A.L. Friedman, M.J. Bia, F. Lakkis, J.D. Smith and M.I. Lorber. The evolving experience using everolimus in clinical transplantation. Transplant. Proc. 36: S495-99 (2004).
10. B. Brazzini and N. Pimpinelli. New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use. Am. J. Clin. Dermatol. 3: 47-58 (2002).
11. F.M. Versaci, A. Gaspardone, F. Tomai, F. Ribichini, P. Russo, I. Proietti, A.S. Ghini, V. Ferrero, L. Chiariello, P.A. Gioffre, F. Romeo and F. Crea. Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation. J. Am. Coll. Cardiol. 40: 1935-42 (2002).
12. R. Altman and A. Scazziota. Role of anti-inflammatory drugs in the treatment of acute coronary syndromes. From athero-inflammation to athero-thrombosis. Rev. Esp. Cardiol. 56: 9-15 (2003).
13. U.S. Patent 20060002968 (2006).
14. F. Streit, V.W. Armstrong and M. Oellerich. Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporine A in whole blood. Clin. Chem. 48: 955-58 (2002).
15. P.J. Taylor, M.E. Franklin, K.S. Graham and P.I. Pillans. A HPLC-mass spectrometric method suitable for the therapeutic drug monitoring of everolimus. J. Chromatogr. B, in press.
16. M. Korecka, S.G. Solari and L.M. Shaw. Sensitive, high throughput HPLC-MS/MS method with on-line sample clean-up for everolimus measurement. Ther. Drug Monit. 28: 484-90 (2006).
17. T. Koal, M. Deters, B. Casetta and V. Kaever. Simultaneous determination of four immunosuppressants by means of high speed and robust on-line solid phase extraction-high performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 805: 215-22 (2004).
18. M. Deters, G. Kirchner, K. Resch and V. Kaever, V. Simultaneous quantification of sirolimus, everolimus, tacrolimus and cyclosporine by liquid chromatography-mass spectrometry (LC-MS). Clin. Chem. Lab. Med. 40: 285-92 (2002).
19. A. Volosov, K.L. Napoli and S.J. Soldin. Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography-tandem mass-spectrometry. Clin. Biochem. 34: 285-90 (2001).
20. T.J. Franz, P.A. Lehman, S.R. Feldman and M.C. Spellman. Bioavailability of clobetasol propionate in different vehicles. Skin Pharmacol. Appl. Skin Physiol. 16: 212-16 (2003).
21. P. Salm, P.J. Taylor, S.V. Lynch and P.I. Pillans. Quantification and stability of everolimus (SDZ RAD) in human blood by high-performance liquid chromatography-electrospray tandem mass spectrometry. J. Chromatogr. B 772: 283-90 (2002).
22. Q. Wang, D. Ma and P.J. Higgins. Analytical Method Selection for Drug Product Dissolution Testing. Dissol. Technol. 13: 6-13 (2006).
23. S. Baldelli, S. Zenoni, S. Merlini, N. Perico and D. Cattaneo. Simultaneous determination of everolimus and cyclosporine concentrations by HPLC with ultraviolet detection. Clin. Chim. Acta 364: 354-8 (2006).
24. G. Khoschsorur. Simultaneous measurement of sirolimus and everolimus in whole blood by HPLC with ultraviolet detection. Clin. Chem. 51: 1721-24 (2005).
25. S. Baldelli, S. Murgia, S. Merlini, S. Zenoni, N. Perico, G. Remuzzi and D. Cattaneo. High-performance liquid chromatography with ultraviolet detection for therapeutic drug monitoring of everolimus. J. Chromatogr. B 816: 99-105 (2005).
26. T.Y. Boudennaia and K.L. Napoli. Validation of a practical liquid chomatography with ultraviolet detection method for quantification of whole-blood everolimus in a clinical TDM laboratory. Ther. Drug Monit. 27: 171-7 (2005).
27. S. Dyderski, E. Grzeskowiak, E. Szalek and A. Mrzyglod. Pharmaceutical availability of clobetasol-17-propionate from cream and ointment. Acta Pol. Pharm. 58: 435-8 (2001).
28. X. Wang, S. Qin, T. Liu, X. Chen and K. Bi. Simultaneous assay and determination of related substances of ketoconazole and clobetasol propionate in the compound ketoconazole cream by RP-HPLC. Xibei Yaoxue Zashi 21: 99-101 (2006).
29. L. Nováková and P. Solich. A comparison of performance of various analytical columns in pharmaceutical analysis: conventional C18 and high throughput C18 zorbax columns. J. Chromatogr. A 1088: 24-31 (2005).
30. T. Greibrokk and T. Andersen. High temperature liquid chromatography. J. Chromatogr. A 1000: 743-55 (2003).
31. C. Zhu, D.M. Goodall and S.A. Wren. Elevated temperature HPLC: principles and applications to small molecules and biomolecules. LC-GC North Amer. 23: 54-72 (2005).
32. A.D. Broske, R. D. Ricker, B.J. Permar, W.Chen and M. Joseph. The influence of sub-two micron particles on HPLC performance. Agilent technologies publication 5988-9251EN